Biotech | September 24, 2021
AstraZeneca to collaborate with VaxEquity for self-amplifying RNA therapy
saRNA is a new platform for the development of medicines and vaccines which uses similar technology to mRNA but with the added ability to self-amplify, thereby expressing proteins for longer, resulting in higher protein levels per dose level
_256_275.jpg)